title: Personalized medicine for cancer therapy: Lessons learned from tumor-associated antigens.
abstract: Antibody signatures may become sophisticated screening tools for early diagnosis and the development of personalized anticancer treatments. We used biopanning to enrich the immune response of head and neck squamous cell carcinoma (HNSCC) patients. This method revealed a HNSCC-specific antibody signature and allowed for the discovery of a novel oncogene,L23.
authors.affiliation: Department of Periodontics and Oral Medicine, School of Dentistry; University of Michigan; Ann Arbor, MI USA.
authors.forename: Christina Springstead
authors.initials: CS
authors.lastname: Scanlon
authors.forename: Nisha J
authors.initials: NJ
authors.lastname: D'Silva
keywords: head and neck squamous cell carcinoma; personalized medicine; phage display; tumor-associated antigens